Associated Papers
Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer.
Yang H et al.
Cancer Cell, 2024
β-Catenin in desmoid-type fibromatosis: deep insights into the role of T41A and S45F mutations on protein structure and gene expression.
Colombo C et al.
Molecular Oncology, 2017
28627792 (PubMed )
Supplement: MOL2-11-1495-s003.docx
RET Aberrations in Diverse Cancers: Next-Generation Sequencing of 4,871 Patients.
Kato S et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2017
27683183 (PubMed )
Supplement: 10780432ccr161679-sup-168576_1_supp_3636667_wcc1ns.docx
Pancreatic desmoid-type fibromatosis with beta-catenin gene mutation-Report of a case and review of the literature.
Tsukamoto Y et al.
Pathology, Research and Practice, 2016
β-catenin (CTNNB1) mutations and clinicopathological features of mesenteric desmoid-type fibromatosis.
Huss S et al.
Histopathology, 2013
Cyclooxygenase-2 and platelet-derived growth factor receptors as potential targets in treating aggressive fibromatosis.
Signoroni S et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2007
Select a paper to view details